Locally advanced breast cancer refers to either large tumors (T3 or T4), involvement of multiple lymph nodes or a combination of both without evidence of carcinoma in distant organs. These patients are situated in stage II or III with prognosis being extremely variable, including 5-year overall survival from 60 to 99% depending on type of treatment received and tumor response to such treatment.